RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 145 filers reported holding RELMADA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 2.08 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $839,281,000 | +226.7% | 22,671 | +67.6% | 0.00% | – |
| Q2 2022 | $256,916,000 | -60.5% | 13,529 | -43.9% | 0.00% | – |
| Q1 2022 | $650,999,000 | +176.4% | 24,120 | +227.8% | 0.00% | – |
| Q2 2021 | $235,530,000 | +4.5% | 7,358 | +15.0% | 0.00% | – |
| Q1 2021 | $225,344,000 | +9.8% | 6,400 | 0.0% | 0.00% | – |
| Q4 2020 | $205,248,000 | -54.2% | 6,400 | -46.2% | 0.00% | – |
| Q3 2020 | $447,678,000 | +81.9% | 11,900 | +116.4% | 0.00% | – |
| Q2 2020 | $246,125,000 | – | 5,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 668,440 | $25,147,000 | 4.92% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $18,810,000 | 3.40% |
| ACUTA CAPITAL PARTNERS, LLC | 277,000 | $10,421,000 | 2.83% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 455,137 | $17,122,000 | 1.67% |
| RTW INVESTMENTS, LP | 1,511,337 | $56,857,000 | 1.37% |
| Avoro Capital Advisors LLC | 1,500,000 | $56,430,000 | 0.80% |
| Pegasus Asset Management, Inc. | 26,958 | $1,014,000 | 0.64% |
| RA Capital Management | 781,290 | $29,392,000 | 0.54% |
| TIEDEMANN ADVISORS, LLC | 269,839 | $10,151,000 | 0.49% |
| Boxer Capital, LLC | 300,000 | $11,286,000 | 0.39% |